STARD3NL and osteoporosis: To test the therapeutic effect of silencing of Stard3nl in vivo, an OVX‐induced osteoporosis model is established and gene targeting by AAV vectors are introduced, which own a long‐term safety and efficacy in both preclinical and clinical studies.36